Evaluation of quality improvement for people with diabetes
Not Applicable
- Conditions
- DiabetesNutritional, Metabolic, EndocrineDiabetes mellitus
- Registration Number
- ISRCTN82176651
- Lead Sponsor
- orthumbria University
- Brief Summary
2023 Protocol article in https://pubmed.ncbi.nlm.nih.gov/37653413/ (added 01/09/2023)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Teams providing specialist diabetes care to adults in England and Wales
Exclusion Criteria
Does not meet the inclusion criteria
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The proportion of adults with poorly controlled type 1 diabetes (HbA1c above 69 mmol/mol) starting and continuing to use insulin pumps for at least 3 months within an 18-month follow-up period
- Secondary Outcome Measures
Name Time Method 1. Change in blood glucose levels as measured by HbA1c in people with poorly controlled type 1 diabetes between the latest measurement in the 12 months preceding the start of the intervention and the latest measurements recorded during the study period<br>2. Any record of insulin pump prescribing, including for periods shorter than 3 months, measured using data routinely collected as part of the National Diabetes Audit over the 18-month follow-up period<br>3. Insulin pump use sustained over at least 6 months, measured using data routinely collected as part of the National Diabetes Audit over the 18-month follow-up period